GZR18, a US subsidiary of Ganli Pharmaceuticals, was approved by the FDA for its clinical trial for the treatment of type 2 diabetes
Innovent's GLP-1R/GCGR dual agonist treatment of type 2 diabetes phase Ib clinical results announced
"Nature" discovers that a new hormone has an important relationship with diabetes and obesity!
The secret of anti-cancer hidden in diabetic patients? New research discovers where the immune army comes from
Free-riding: How phages use a network of bacteria and fungi to spread in the soil
Sub-Journal of The Lancet: Dapagliflozin reduces new-onset diabetes by 33%, and two key studies add evidence of benefit!
Scissors are still in chaos, the inextricable connection between diabetes and atrial fibrillation
"Guidelines for Diagnosis and Treatment of Diabetes in the Elderly in China (2021 Edition)" topped
Diabetes drugs have two more benefits, or to achieve both specimens
This pharmaceutical company raised US$120 million to develop innovative treatments for diabetes
Atrial fibrillation with diabetes, heart failure or kidney disease
Diabetes classification and controversy: 2022 version of ADA diabetes diagnosis and treatment standards
Talk about ADA's trip to China for three years, new expectations for diabetes management
Weight loss + hypoglycemic "two-pronged approach", will the next breakthrough direction of diabetes treatment be "it"?
PNAS: The secret of new coronavirus spreading between cells
Prof. Li Guangwei: The tenacious β-cells are waiting to be awakened, looking at future disease management from the "root" of diabetes
Reliance on the elderly, in-depth discussion of the management plan for elderly diabetes
How to optimize the treatment plan to bring better blood sugar control to patients with short-term type 2 diabetes
Sub-Journal of "Science": Run more, don't look for diabetes!
Individualized management helps diabetic patients benefit in multiple ways